PatientMatch — Privacy-first clinical trial discovery

Showing 1–24 of 65 trials

Enrolling now

Nationwide

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

National Cancer Institute (NCI)

Ph 2·~5yr·1 site in MD

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

64Cu-LNTH-1363S Trial

Lantheus Medical Imaging

Ph 1/2·~8mo·5 sites in CA, MI, OH

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Phase Ⅲ Clinical Trial of HLX22

Shanghai Henlius Biotech

Ph 3·~4yr·29 sites in CA, CO, FL +11

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Daiichi Sankyo

Ph 2·~5yr·13 sites in CA, CT, FL +8

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of ETX-19477 in Patients With Advanced Solid Malignancies

858 Therapeutics, Inc.

Ph 1/2·~3yr·14 sites in AZ, CT, FL +10

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Sutro Biopharma, Inc.

Ph 1·~2yr·6 sites in CO, FL, MA +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

BeiGene

Ph 1·~4yr·6 sites in CA, FL, MO +3

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NiKang Therapeutics, Inc.

Ph 1·~5yr·19 sites in AR, CA, CO +10

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Gene Transfer Trial for Cancer

National Cancer Institute (NCI)

Ph 1/2·~11yr·1 site in MD

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

AZD0901 vs. Other Treatments in Gastric Cancer

AstraZeneca

Ph 3·~3yr·38 sites in AL, AZ, CA +16

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

AZD0901 for Advanced Tumors

AstraZeneca

Ph 2·~3yr·7 sites in CA, KY, NY +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Combination of TATE and PD-1 Inhibitor in Liver Cancer

Teclison Ltd.

Ph 2·~9yr·3 sites in CA, OK, WI

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Ph 1·2 sites in TX, UT

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Dose Escalation and Dose Expansion Study of MDX2001

ModeX Therapeutics, An OPKO Health Company

Ph 1/2·~5yr·6 sites in CO, FL, MA +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

IDOV-Immune Trial

ViroMissile, Inc.

Ph 1·~2yr·3 sites in MO, TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

IKS014 Trial for Advanced Cancer

Iksuda Therapeutics Ltd.

Ph 1·~4yr·3 sites in CA, MA, TN

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Christian Hinrichs

Ph 1·~6yr·2 sites in NJ

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Perspective Therapeutics

Ph 1/2·~7yr·3 sites in MO, NE, PA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Novel Drug Combinations for Gastric Cancer

AstraZeneca

Ph 2·~5yr·11 sites in CA, LA, MI +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

DESTINY-Gastric03 Trial

AstraZeneca

Ph 2·~7yr·10 sites in CA, KS, MA +6

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Advanced Gastric Cancer

University of Chicago

Ph 2·~9mo·1 site in IL

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

AstraZeneca

Ph 3·69 sites in AR, AZ, CA +27

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

AZD4360 Trial for Advanced Solid Tumours

AstraZeneca

Ph 1/2·~3yr·3 sites in CA, RI, TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

EMD Serono Research & Development Institute, Inc.

Ph 1/2·~3yr·11 sites in CA, DC, FL +4

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify